Bioorganic and Medicinal Chemistry Letters p. 3133 - 3136 (1998)
Update date:2022-09-26
Topics:
Smith III, Amos B.
Sasho, Setsuya
Barwis, Bari A.
Sprengeler, Paul
Barbosa, Joseph
Hirschmann, Ralph
Cooperman, Barry S.
A tetrahydropyran-based inhibitor (2) of mammalian ribonucleotide reductase (mRR) has been designed and synthesized based on the heptapeptide, N-AcFTLDADF (1), corresponding to the C-terminus of the R2 subunit of mRR. Inhibition studies revealed that 2 is indeed a competent inhibitor, albeit less potent than 1.
View MoreContact:+86-27-85733560
Address:NO.308,QINGNIAN RD.,WUHAN,CHINA
Contact:18669908765
Address:Zibo City, Shandong Province, P.R.China
Tianjin Anda North Industrial & Business Co.Ltd.
Contact:86-22-24999306
Address:No.11 Erwei Road,Dongli Development Area,Tianjin,China
Hangzhou innopharma technology Co,.Ltd.(expird)
Contact:+86-13388601988
Address:Room845,lixin building, moganshan road, hangzhou, china
Nanjing Norris Pharm Technology Co., Ltd.
Contact:+86-13901585132
Address:2 Qiande Road, Jiangning sciencepark Hi-Tech Zone, Nanjing, P.R.China
Doi:10.1016/S0040-4039(99)02297-2
(2000)Doi:10.1039/DT9870002723
(1987)Doi:10.1021/ol005504g
(2000)Doi:10.1021/ol0056832
(2000)Doi:10.1016/S0040-4020(01)92757-7
(1970)Doi:10.1023/A:1015022032506
(2002)
